Patient basic information Patient: Ms. Anastasia Thompson) Nationality: Finland Diagnosis: Blue Eye Diagnostic hospital: H0O treatment: blood stem cell transplant + chemotherapy Accommodation days: 180 days Treatment cost: about 210,973 yuan Treatment effect: Complete alleviation Description of the condition Ms. Anastasia is from Finland and was diagnosed as blue eye locally.
Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs. After 180 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.
The patient's treatment effects were finally completely alleviated. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to monitor the recovery through the remote follow-up system. 'Mrs.
Anastasia has been criticized by experts as a typical case of cross-border suspected seriousness in clinical cases. A multi-disciplinary collaborative mechanism for the development of a blood stem cell transplant + chemotherapy program aimed at the blue eye reflects the comprehensive strength of Chinese hospitals in the field of diagnostics of suspected diseases and a summary of how international medical services are regulated.